Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (ATYR)
NASDAQ:ATYR
Holding ATYR?
Track your performance easily
ATYR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.08 - $2.50
Previous Close$1.82
Volume62.24K
Average Volume (3M)394.52K
Market Cap
$140.98M
Enterprise Value$73.13M
Total Cash (Recent Filing)$78.48M
Total Debt (Recent Filing)$13.85M
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Nov 07, 2024EPS Estimate
-$0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding75,796,198
10 Day Avg. Volume480,161
30 Day Avg. Volume394,516
Standard Deviation0.18
R-Squared0.13
Alpha-0.00811
Financial Highlights & Ratios
Price to Book (P/B)1.69
Price to Sales (P/S)237.19
Price to Cash Flow (P/CF)-1.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue124.38
Enterprise Value/Gross Profit207.18
Enterprise Value/Ebitda-1.26
Forecast
1Y Price Target
$20.50Price Target Upside1002.15% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
aTyr Pharma News
Ownership Overview
2.67% Insiders
26.50% Mutual Funds
22.36% Other Institutional Investors
48.46% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ATYR FAQ
What was aTyr Pharma’s price range in the past 12 months?
aTyr Pharma lowest stock price was $1.08 and its highest was $2.50 in the past 12 months.
What is aTyr Pharma’s market cap?
Currently, no data Available
When is aTyr Pharma’s upcoming earnings report date?
aTyr Pharma’s upcoming earnings report date is Nov 07, 2024 which is in 48 days.
How were aTyr Pharma’s earnings last quarter?
aTyr Pharma released its earnings results on Aug 13, 2024. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.253 by $0.023.
Is aTyr Pharma overvalued?
According to Wall Street analysts aTyr Pharma’s price is currently Undervalued.
Does aTyr Pharma pay dividends?
aTyr Pharma does not currently pay dividends.
What is aTyr Pharma’s EPS estimate?
aTyr Pharma’s EPS estimate is -$0.22.
How many shares outstanding does aTyr Pharma have?
aTyr Pharma has 75,796,196 shares outstanding.
What happened to aTyr Pharma’s price movement after its last earnings report?
aTyr Pharma reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.253. Following the earnings report the stock price went up 6.322%.
Which hedge fund is a major shareholder of aTyr Pharma?
Among the largest hedge funds holding aTyr Pharma’s share is Woodline Partners LP. It holds aTyr Pharma’s shares valued at 3M.
---
aTyr Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.50 (1002.15% Upside)
$20.50 (1002.15% Upside)
Blogger Sentiment
Bullish
ATYR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $184.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.04%
12-Months-Change
Fundamentals
Return on Equity
-61.64%
Trailing 12-Months
Asset Growth
-20.19%
Trailing 12-Months
Company Description
aTyr Pharma
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
---
ATYR Earnings Call
Q4 2024
0:00 / 0:00
---
ATYR Stock 12 Month Forecast
Average Price Target
$20.50
▲(1002.15% Upside)
Technical Analysis
Best Analysts Covering ATYR
1 Year
1 Year Success Rate
4/6 ratings generated profit
1 Year Average Return
+14.62%
reiterated a buy rating 5 months ago
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +14.62% per trade.
---